Ablashi, D. V., Chatlynne, L. G., Whitman, J. E., Jr., & Cesarman, E. (2002). Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev, 15(3), 439-464. doi:10.1128/cmr.15.3.439-464.2002
Ahmed, F. E., Jeffries, C. D., Vos, P. W., Flake, G., Nuovo, G. J., Sinar, D. R., . . . Marcuard, S. P. (2009). Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue. Cancer Genomics Proteomics, 6(5), 281-295.
Amerson, E., Woodruff, C. M., Forrestel, A., Wenger, M., McCalmont, T., LeBoit, P., . . . Martin, J. (2016). Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa. J Acquir Immune Defic Syndr, 71(3), 295-301. doi:10.1097/qai.0000000000000862
Auten, M., Kim, A. S., Bradley, K. T., & Rosado, F. G. (2017). Human herpesvirus 8-related diseases: Histopathologic diagnosis and disease mechanisms. Semin Diagn Pathol, 34(4), 371-376. doi:10.1053/j.semdp.2017.04.004
Blondal, T., Jensby Nielsen, S., Baker, A., Andreasen, D., Mouritzen, P., Wrang Teilum, M., & Dahlsveen, I. K. (2013). Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods, 59(1), S1-6. doi:10.1016/j.ymeth.2012.09.015
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., . . . Croce, C. M. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med, 353(17), 1793-1801. doi:10.1056/NEJMoa050995
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., . . . Zhang, C. Y. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18(10), 997-1006. doi:10.1038/cr.2008.282
Corey Casper, Martin S Hirsch, & Bloom, A. (2019). Diagnosis and antiviral therapy of human herpesvirus 8 infection. Retrieved May 10, 2020, from UpToDate https://www.uptodate.com/contents/diagnosis-and-antiviral-therapy-of-human-herpesvirus-8-infection
Dave, V. P., Ngo, T. A., Pernestig, A.-K., Tilevik, D., Kant, K., Nguyen, T., . . . Bang, D. D. (2019). MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics. Laboratory Investigation, 99(4), 452-469. doi:10.1038/s41374-018-0143-3
Eitan, R., Kushnir, M., Lithwick-Yanai, G., David, M. B., Hoshen, M., Glezerman, M., . . . Levavi, H. (2009). Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol, 114(2), 253-259. doi:10.1016/j.ygyno.2009.04.024
Freeman, E., Semeere, A., Wenger, M., Bwana, M., Asirwa, F. C., Busakhala, N., . . . Martin, J. (2016). Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa. BMC Cancer, 16, 65. doi:10.1186/s12885-016-2080-0
Gilad, S., Lithwick-Yanai, G., Barshack, I., Benjamin, S., Krivitsky, I., Edmonston, T. B., . . . Aharonov, R. (2012). Classification of the Four Main Types of Lung Cancer Using a MicroRNA-Based Diagnostic Assay. The Journal of Molecular Diagnostics, 14(5), 510-517. doi:10.1016/j.jmoldx.2012.03.004
Griffiths-Jones, S., Grocock, R. J., van Dongen, S., Bateman, A., & Enright, A. J. (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res, 34(Database issue), D140-144. doi:10.1093/nar/gkj112
Gustafson, D., Tyryshkin, K., & Renwick, N. (2016). microRNA-guided diagnostics in clinical samples. Best Practice & Research Clinical Endocrinology & Metabolism, 30(5), 563-575. doi:https://doi.org/10.1016/j.beem.2016.07.002
Hoshina, S., Sekizuka, T., Kataoka, M., Hasegawa, H., Hamada, H., Kuroda, M., & Katano, H. (2016). Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell Lines. PLoS One, 11(9), e0162574. doi:10.1371/journal.pone.0162574
Hussein, H. A. M., & Akula, S. M. (2017). Profiling of cellular microRNA responses during the early stages of KSHV infection. Archives of Virology, 162(11), 3293-3303. doi:10.1007/s00705-017-3478-y
Ji, J., Shi, J., Budhu, A., Yu, Z., Forgues, M., Roessler, S., . . . Wang, X. W. (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med, 361(15), 1437-1447. doi:10.1056/NEJMoa0901282
Kadri, F., LaPlante, A., De Luca, M., Doyle, L., Velasco-Gonzalez, C., Patterson, J. R., . . . Peruzzi, F. (2016). Defining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected Patients. J Cell Physiol, 231(4), 829-836. doi:10.1002/jcp.25131
Lagos, D., Pollara, G., Henderson, S., Gratrix, F., Fabani, M., Milne, R. S. B., . . . Boshoff, C. (2010). miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nature Cell Biology, 12(5), 513-519. doi:10.1038/ncb2054
Lu, Y., Baras, A. S., & Halushka, M. K. (2018). miRge 2.0 for comprehensive analysis of microRNA sequencing data. BMC Bioinformatics, 19(1), 275. doi:10.1186/s12859-018-2287-y
Machado, P. R., Farias, K. J., Pereira, M. G., Freitas, P. P., & Fonseca, B. A. (2015). Human herpesvirus 8 (HHV-8) detected by nested polymerase chain reaction (PCR) in HIV patients with or without Kaposi's sarcoma. An analytic cross-sectional study. Sao Paulo Med J, 134(3), 187-192. doi:10.1590/1516-3180.2014.8973010
Mosam, A., Shaik, F., Uldrick, T. S., Esterhuizen, T., Friedland, G. H., Scadden, D. T., . . . Coovadia, H. M. (2012). A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr, 60(2), 150-157. doi:10.1097/QAI.0b013e318251aedd
Munshi, S. U., Panda, H., Holla, P., Rewari, B. B., & Jameel, S. (2014). MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy. PLoS One, 9(5), e95920. doi:10.1371/journal.pone.0095920
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018). Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Frontiers in Endocrinology, 9(402). doi:10.3389/fendo.2018.00402
Okuku, F., Krantz, E. M., Kafeero, J., Kamya, M. R., Orem, J., Casper, C., & Phipps, W. (2017). Evaluation of a Predictive Staging Model for HIV-Associated Kaposi Sarcoma in Uganda. J Acquir Immune Defic Syndr, 74(5), 548-554. doi:10.1097/qai.0000000000001286
Phipps, W., Ssewankambo, F., Nguyen, H., Saracino, M., Wald, A., Corey, L., . . . Casper, C. (2010). Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda. PLoS One, 5(11), e13936. doi:10.1371/journal.pone.0013936
Punj, V., Matta, H., Schamus, S., Tamewitz, A., Anyang, B., & Chaudhary, P. M. (2010). Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene, 29(12), 1835-1844. doi:10.1038/onc.2009.460
Qi, Y., Hu, H., Guo, H., Xu, P., Shi, Z., Huan, X., . . . Cui, L. (2017). MicroRNA profiling in plasma of HIV-1 infected patients: potential markers of infection and immune status. Journal of Public Health and Emergency, 1(7).
Qin, Z., Peruzzi, F., Reiss, K., & Dai, L. (2014). Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis. Viruses, 6(11), 4571-4580. doi:10.3390/v6114571
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26(1), 139-140. doi:10.1093/bioinformatics/btp616
Shatseva, T., Lee, D. Y., Deng, Z., & Yang, B. B. (2011). MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. Journal of Cell Science, 124(16), 2826-2836. doi:10.1242/jcs.077529
Sohel, M. H. (2016). Extracellular/Circulating MicroRNAs: Release Mechanisms, Functions and Challenges. Achievements in the Life Sciences, 10(2), 175-186. doi:https://doi.org/10.1016/j.als.2016.11.007
Stebbing, J., Portsmouth, S., & Gazzard, B. (2003). How does HAART lead to the resolution of Kaposi's sarcoma? J Antimicrob Chemother, 51(5), 1095-1098. doi:10.1093/jac/dkg199
Stenfeldt, C., Arzt, J., Smoliga, G., LaRocco, M., Gutkoska, J., & Lawrence, P. (2017). Proof-of-concept study: profile of circulating microRNAs in Bovine serum harvested during acute and persistent FMDV infection. Virology Journal, 14(1), 71. doi:10.1186/s12985-017-0743-3
Su, B., Fu, Y., Liu, Y., Wu, H., Ma, P., Zeng, W., . . . Wu, H. (2018). Potential Application of MicroRNA Profiling to the Diagnosis and Prognosis of HIV-1 Infection. Front Microbiol, 9, 3185. doi:10.3389/fmicb.2018.03185
Turchinovich, A., Samatov, T. R., Tonevitsky, A. G., & Burwinkel, B. (2013). Circulating miRNAs: cell-cell communication function? Front Genet, 4, 119. doi:10.3389/fgene.2013.00119
Viollet, C., Davis, D. A., Tekeste, S. S., Reczko, M., Ziegelbauer, J. M., Pezzella, F., . . . Yarchoan, R. (2017). RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature. PLOS Pathogens, 13(1), e1006143. doi:10.1371/journal.ppat.1006143
Wang, H., Peng, R., Wang, J., Qin, Z., & Xue, L. (2018). Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage. Clinical Epigenetics, 10(1), 59. doi:10.1186/s13148-018-0492-1
Wu, X. J., Pu, X. M., Zhao, Z. F., Zhao, Y. N., Kang, X. J., Wu, W. D., . . . Liu, J. Y. (2015). The expression profiles of microRNAs in Kaposi's sarcoma. Tumour Biol, 36(1), 437-446. doi:10.1007/s13277-014-2626-1
Yang, Z., Chen, J.-S., Wen, J.-K., Gao, H.-T., Zheng, B., Qu, C.-B., . . . Zhang, Y. (2017). Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. Journal of Experimental & Clinical Cancer Research, 36(1), 178. doi:10.1186/s13046-017-0649-3
Yaqub, S., Stepenaskie, S. A., Farshami, F. J., Sibbitt, W. L., Jr., Fangtham, M., Emil, N. S., & Bankhurst, A. D. (2019). Kaposi Sarcoma as a Cutaneous Vasculitis Mimic: Diagnosis and Treatment. J Clin Aesthet Dermatol, 12(11), 23-26.
Ye, F., Lei, X., & Gao, S. J. (2011). Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation. Adv Virol, 2011. doi:10.1155/2011/193860
Yu, H., Guan, Z., Cuk, K., Zhang, Y., & Brenner, H. (2019). Circulating MicroRNA Biomarkers for Lung Cancer Detection in East Asian Populations. Cancers (Basel), 11(3). doi:10.3390/cancers11030415